Drug policy and global regulatory capitalism: The case of new psychoactive substances (NPS)

International Journal of Drug Policy

Volumn 25, Issue 5, 2014, Pages 1019-1024

  Seddon, Toby ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Governance; Legal highs; Markets; New psychoactive substances; Regulation

Indexed keywords

CANNABIS; LYSERGIDE; NEW DRUG; OPIATE; PSYCHOTROPIC AGENT;

ARTICLE; CLASSIFICATION; COMMERCIAL PHENOMENA; CONSUMER; CRIMINAL LAW; DRUG CONTROL; DRUG POLICY; GOVERNMENT; HEALTH CARE QUALITY; HUMAN; INTERNET; LAW ENFORCEMENT; NEW ZEALAND; POLICY; POLITICAL SYSTEM; PRIORITY JOURNAL; SOCIAL CHANGE; HEALTH CARE POLICY; LEGISLATION AND JURISPRUDENCE; MANAGEMENT; TRENDS;

CAPITALISM; COMMERCE; DRUG AND NARCOTIC CONTROL; HEALTH POLICY; HUMANS; POLICY MAKING; PSYCHOTROPIC DRUGS;

EID: 84924062867     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2014.03.009     Document Type: Article

References (53)

1. Advisory Council on the Misuse of Drugs (ACMD) Consideration of the novel psychoactive substances ('legal highs') 2011, Home Office, London.
2. Ayling J., Grabosky P., Shearing C. Lengthening the arm of the law: Enhancing police resources in the twenty-first century 2009, Cambridge University Press, Cambridge.
3. Ayres I., Braithwaite J. Responsive regulation: Transcending the deregulation debate 1992, Oxford University Press, Oxford.
4. Babor T., Caetano R., Casswell S., Edwards G., Giesbrecht N., Graham K., et al. Alcohol: No ordinary commodity: Research and public policy 2010, Oxford University Press, Oxford. 2nd ed.
5. Berridge V. AIDS and British drugs policy: History repeats itself?. Policing and prescribing: The British system of drug control 1991, Macmillan, London. D. Whynes, P. Bean (Eds.).
6. Berridge V., Hickman T. History and the future of psychoactive substances. Drugs and the future: Brain science, addiction and society 2006, Elsevier, Amsterdam. D. Nutt, T. Robbins, G. Stimson, M. Ince, A. Jackson (Eds.).
7. Black J. Decentring regulation: The role of regulation and self-regulation in a 'post-regulatory' world. Current Legal Problems 2001, 54:103-146.
8. Black J. The rise, fall and fate of principles based regulation. LSE law, society and economy working papers 17/2010 2010, LSE, London.
9. Braithwaite J. Rules and principles: A theory of legal certainty. Australian Journal of Legal Philosophy 2002, 27:47-82.
10. Braithwaite J. Markets in vice, markets in virtue 2005, Federation Press, Sydney.
11. Braithwaite J. Regulatory capitalism: How it works, ideas for making it work better 2008, Edward Elgar, Cheltenham.
12. Braithwaite J. The essence of responsive regulation. UBC Law Review 2011, 44(3):475-520.
13. Burris S., Drahos P., Shearing C. Nodal governance. Australian Journal of Legal Philosophy 2005, 30:30-58.
14. Cherney A., O'Reilly J., Grabosky P. Networks and meta-regulation: Strategies aimed at governing synthetic illicit drugs. Policing & Society 2006, 16(4):370-385.
15. Collins H. Regulating contracts 1999, Oxford University Press, Oxford.
16. Corazza O., Demetrovics Z., van den Brink W., Schifano F. 'Legal highs' an inappropriate term for 'novel psychoactive drugs' in drug prevention and scientific debate. International Journal of Drug Policy 2013, 24:82-83.
17. Coulson C., Caulkins J. Scheduling of newly emerging drugs: A critical review of decisions over 40 years. Addiction 2012, 107:766-773.
18. Davies S., Wood D., Smith G., Button J., Ramsey J., Archer R., et al. Purchasing 'legal highs' on the Internet - Is there consistency in what you get?. Quarterly Journal of Medicine 2010, 103:489-493.
19. EMCDDA and Europol EU drug markets report: A strategic analysis 2013, EMCDDA, Lisbon.
20. EMCDDA and Europol New drugs in Europe, 2012: EMCDDA-Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA 2013, EMCDDA, Lisbon.
21. European Commission European Commission takes decisive action against legal highs 2013, European Commission, Brussels, European Commission Press Release IP/13/837, 17/09/13.
22. Grabosky P. Using non-governmental resources to foster regulatory compliance. Governance: An International Journal of Policy & Administration 1995, 8(4):527-550.
23. Griffiths P., Sedefov R., Gallegos A., Lopez D. How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case study. Addiction 2010, 105:951-953.
24. Griffiths P., Evans-Brown M., Sedefov R. Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age. Addiction 2013, 108:1700-1703.
25. Gunningham N. The new collaborative environmental governance: The localization of regulation. Journal of Law & Society 2009, 36(1):145-166.
26. Howells G. The potential and limits of consumer empowerment by information. Journal of Law & Society 2005, 32(3):349-370.
27. Hughes B., Winstock A. Controlling new drugs under marketing regulations. Addiction 2011, 107:1894-1899.
28. Hyde R. Why separate the regulatory regimes applicable to food safety and product safety?. Legal Studies 2013, 33(4):509-531.
29. Levi-Faur D. The global diffusion of regulatory capitalism. The Annals of the American Academy of Political and Social Science 2005, 598(1):12-32.
30. Mathers B., Degenhardt L., Ali H., Wiessing L., Hickman M., Mattick R., et al. HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. The Lancet 2010, 375:1014-1028.
31. Mazerolle L., Ransley J. Third party policing. Cambridge studies in criminology 2006, Cambridge University Press, Cambridge.
32. Measham F. Legal highs: The challenge for government. Criminal Justice Matters 2011, 84:28-30.
33. Measham F., Moore K., Newcombe R., Welch Z. Tweaking, bombing, dapping and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drugs and Alcohol Today 2010, 10(1):14-21.
34. New Zealand Law Commission Controlling and regulating drugs: A review of the Misuse of Drugs Act 1975. Report No 122 2011, New Zealand Law Commission, Wellington.
35. Norman J., Grace S., Lloyd C. Legal high groups on the internet - The creation of new organized deviant groups?. Drugs: Education, Prevention & Policy 2014, 21(1):14-23.
36. Post D. Standards and regulatory capitalism: The diffusion of food safety standards in developing countries. The Annals of the American Academy of Political and Social Science 2005, 598(1):168-183.
37. Ramsay I. Consumer law, regulatory capitalism and the 'new learning' in regulation. Sydney Law Review 2006, 28:9-35.
38. Reuter P. Options for regulating new psychoactive substances: A review of recent experiences 2011, UKDPC, London.
39. Ritter A. Illicit drugs policy through the lens of regulation. International Journal of Drug Policy 2010, 21(4):265-270.
40. Schwitters B., Achanta G., van der Vlies D., Morisset H., Bast A., Hanekamp J. The European regulation of food supplements and food fortification: Intended normal use - The ultimate tool in organising level playing field markets and regulations, or how to break the fairy ring around 'other substances'. Environmental Law & Management 2007, 19(1):19-29.
41. Scott C. Regulatory innovation and the online consumer. Law & Policy 2004, 26(3 & 4):477-506.
42. Seddon T. Let's not talk about drugs. Drugs & Alcohol Today 2010, 10(3):21-23.
43. Seddon T. Regulating global drug problems. RegNet Research Paper 2013/6 2013, RegNet, Australian National University, Canberra.
44. Shearing C. A constitutive conception of regulation. Business regulation and Australia's future 1993, Australian Institute of Criminology, Canberra. P. Grabosky, J. Braithwaite (Eds.).
45. Stimson G., Lart R. HIV, drugs and public health in England: New words, old tunes. International Journal of the Addictions 1991, 26:1263-1277.
46. Sumnall H., Evans-Brown M., McVeigh J. Social, policy, and public health perspectives on new psychoactive substances. Drug Testing and Analysis 2011, 3(7-8):515-523.
47. Teubner G. Substantive and reflexive elements in modern law. Law & Society Review 1983, 17(2):239-285.
48. United Nations Office on Drugs and Crime (UNODC) The challenge of new psychoactive substances. A report from the Global SMART Programme 2013, UNODC, Vienna.
49. United Nations Office on Drugs and Crime (UNODC) World Drug Report 2013 2013, UNODC, Vienna.
50. van Amsterdam J., Nutt D., van den Brink W. Generic legislation of new psychoactive drugs. Journal of Psychopharmacology 2013, 27(3):317-324.
51. Van Hout M., Bingham T. 'Silk road', the virtual drug marketplace: A single case study of user experiences. International Journal of Drug Policy 2013, 24(5):385-391.
52. Vogel S. Freer markets, more rules: Regulatory reform in advanced industrial economies 1996, Cornell University Press, Ithaca.
53. Winstock A., Wilkins C. 'Legal highs': The challenge of new psychoactive substances. Series on Legislative Reform of Drug Policies Nr. 16 2011, Transnational Institute, Amsterdam.